Literature DB >> 35023983

DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments.

Offer Erez1,2, Maha Othman3, Anat Rabinovich4, Elad Leron5, Francesca Gotsch6, Jecko Thachil7.   

Abstract

Obstetrical hemorrhage and especially DIC (disseminated intravascular coagulation) is a leading cause for maternal mortality across the globe, often secondary to underlying maternal and/or fetal complications including placental abruption, amniotic fluid embolism, HELLP syndrome (hemolysis, elevated liver enzymes and low platelets), retained stillbirth and acute fatty liver of pregnancy. Various obstetrical disorders can present with DIC as a complication; thus, increased awareness is key to diagnosing the condition. DIC patients can present to clinicians who may not be experienced in a variety of aspects of thrombosis and hemostasis. Hence, DIC diagnosis is often only entertained when the patient already developed uncontrollable bleeding or multi-organ failure, all of which represent unsalvageable scenarios. Beyond the clinical presentations, the main issue with DIC diagnosis is in relation to coagulation test abnormalities. It is widely believed that in DIC, patients will have prolonged prothrombin time (PT) and partial thromboplastin time (PTT), thrombocytopenia, low fibrinogen, and raised D-dimers. Diagnosis of DIC can be elusive during pregnancy and requires vigilance and knowledge of the physiologic changes during pregnancy. It can be facilitated by using a pregnancy specific DIC score including three components: 1) fibrinogen concentrations; 2) the PT difference - relating to the difference in PT result between the patient's plasma and the laboratory control; and 3) platelet count. At a cutoff of ≥26 points, the pregnancy specific DIC score has 88% sensitivity, 96% specificity, a positive likelihood ratio (LR) of 22, and a negative LR of 0.125. Management of DIC during pregnancy requires a prompt attention to the underlying condition leading to this complication, including the delivery of the patient, and correction of the hemostatic problem that can be guided by point of care testing adjusted for pregnancy.
© 2022 Erez et al.

Entities:  

Keywords:  DIC; hyperfibrinolysis; maternal mortality; placental abruption; pregnancy specific DIC score; thrombin

Year:  2022        PMID: 35023983      PMCID: PMC8747805          DOI: 10.2147/JBM.S273047

Source DB:  PubMed          Journal:  J Blood Med        ISSN: 1179-2736


  190 in total

Review 1.  Placental abruption.

Authors:  Yinka Oyelese; Cande V Ananth
Journal:  Obstet Gynecol       Date:  2006-10       Impact factor: 7.661

2.  Blood coagulation and fibrinolysis during normal pregnancy.

Authors:  J W van Wersch; J M Ubachs
Journal:  Eur J Clin Chem Clin Biochem       Date:  1991-01

3.  Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation.

Authors:  J Erlich; G C Parry; C Fearns; M Muller; P Carmeliet; T Luther; N Mackman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Amnioplastin: new reagent for coagulation tests.

Authors:  D Creter
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

Review 5.  Disseminated intravascular coagulation: a review for the internist.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Intern Emerg Med       Date:  2012-09-27       Impact factor: 3.397

Review 6.  Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage.

Authors:  Natascha M de Lange; Marcus D Lancé; Reneé de Groot; Erik A M Beckers; Yvonne M Henskens; Hubertina C J Scheepers
Journal:  Obstet Gynecol Surv       Date:  2012-07       Impact factor: 2.347

7.  Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in culture.

Authors:  P Reverdiau; A C Jarousseau; G Thibault; B Khalfoun; H Watier; Y Lebranchu; P Bardos; Y Gruel
Journal:  Thromb Haemost       Date:  1995-01       Impact factor: 5.249

8.  "Systematic review of viscoelastic testing (TEG/ROTEM) in obstetrics and recommendation from the women's SSC of the ISTH": Response to comment from Kitchen et al.

Authors:  Emmanuel J Favaloro; Ariunzaya Amgalan; Terrence Allen; Maha Othman; Homa K Ahmadzia
Journal:  J Thromb Haemost       Date:  2020-09       Impact factor: 5.824

9.  Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation.

Authors:  Massimo Franchini; Giuseppe Lippi; Franco Manzato
Journal:  Thromb J       Date:  2006-02-21

10.  Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy: lessons from a cluster of familial cases.

Authors:  Shayna Miodownik; Oleg Pikovsky; Offer Erez; Yarden Kezerle; Oleg Lavon; Anat Rabinovich
Journal:  Am J Obstet Gynecol       Date:  2021-02-20       Impact factor: 8.661

View more
  1 in total

1.  Comparative Proteomic Assessment of Normal vs. Polyhydramnios Amniotic Fluid Based on Computational Analysis.

Authors:  Rūta Navakauskienė; Sandra Baronaitė; Dalius Matuzevičius; Natalija Krasovskaja; Gražina Treigytė; Audronė Arlauskienė; Dalius Navakauskas
Journal:  Biomedicines       Date:  2022-07-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.